The National Institutes of Health, Washington, D.C., discontinued a study on the benefits of hormone replacement therapy (HRT) in mid-2002, when intermediate results showed an increased risk of cardiovascular disease and cancer. This increased interest in alternative therapies for the relief of menopausal symptoms.
Solbar Plant Extracts Ltd. (SPE), Ashdod, Israel, has sponsored studies showing soy isoflavones to benefit two health conditions, hot flushes and osteoporosis, which are associated with menopause. The company has released the results of two additional clinical studies that support soy isoflavones benefits for type II diabetes and memory function in postmenopausal women. Researchers at the Center for Diabetes and Endocrinology, in affiliation with Hull University, U.K., found that isoflavone supplementation (132mg/day Solgen 40 isoflavones extract) resulted in significantly lower mean values for blood components associated with diabetes and cardiovascular risk profile. These included factors such as fasting insulin, insulin resistance, glycated hemoglobin, total cholesterol, low to high cholesterol density lipoprotein (LDL-C/HDL-C) ratio and free thyroxin.
At Kings College, University of London, cognitive tests showed that isoflavone supplementation (60mg/day Solgen 40, given as a divided dose) significantly improved overall memory function. Natural SOLGEN soy isoflavone extracts are formulated in 40, 30 and 20% soy isoflavones concentrations.
Other Solbar ingredients include its Bontex line of steam-textured soy proteins and its Solcon S line of soy protein concentrate for applications in meat and non-meat applications.
Solbar's soy proteins and soy isoflavones are available from non-GMO identity preserved soybeans. Its three factory plants are certified ISO 9002 and Kosher.
Solbar Hatzor Ltd.